If they do it better, then they DO make the difference between life and death. You can't be 'mostly' alive because your medicines 'mostly' did the job.None of these medicines are the difference between life and death, they do what older, patent free medications do but better. Medicare should be willing to give seniors older forms of insulin for example to save money.
If only you could patent the novel patent abuse techniques.It's pretty shocking to see that the sticker price for lantus, an insulin that has been on the market for over 2 decades, has risen so much. It should have been off patent almost 10 years ago. According to this Stat article, secondary patents were used to fend off generic competion for longer: https://www.statnews.com/2018/12/07/patent-abuse-rising-drug-prices-lantus/
I wonder to what extent this kind of practice used to prevent generic competition is a factor behind the price hikes of these meds.
I'm not an expert on the specific ways you can challenge drug prices, but it sounds like this is exactly the problem that collective bargaining solves since the government is itself a market force. My point still stands.The market won't bear anything because the cost isn't passed onto the consumer directly nor are we even looking at the effects since we're effectively printing money to cover this.
All of the costs is getting piled into debt, and a lot of that is the national debt (since it's medicare) that no one in congress cares about since it's just a invisible number to them.
They have paid generic companies to delay introduction, and lately many of the generic companies seeing the money that can be made have increased their prices quite a bit as well, so long as they are cheaper even by a few percent they can still make a killing and many of the generics aren't produced by multiple companies. Using secondary patents or claiming an old version is no longer safe to be used, so you need to use the new version instead which also has a new patent is a typical way drug companies have gotten around patent limits.It's pretty shocking to see that the sticker price for lantus, an insulin that has been on the market for over 2 decades, has risen so much. It should have been off patent almost 10 years ago. According to this Stat article, secondary patents were used to fend off generic competion for longer: https://www.statnews.com/2018/12/07/patent-abuse-rising-drug-prices-lantus/
I wonder to what extent this kind of practice used to prevent generic competition is a factor behind the price hikes of these meds.
Read as, "But my bonus will be smaller! That's un-American!"Drug makers also claim negotiating prices will cut into profits, preventing them from funding research and development into new drugs.
I wouldnt even let them listen to pink floyd. Maybe they deserve baby shark insteadI'm not revolutionary socialist by any means, I'm far from it, but some people just deserve the wall.
Those trials are often funded by the NIH at taxpayer expense. They aren't the source of the costs of drugs. Try again...The reason those small companies get bought out and can't do it alone is because they do not have the money to afford bringing the drug to market. Clinical trials cost too much money!
Pigs squeal real loud when you take the trough away...
That's literally not how generic drugs work.The reason those small companies get bought out and can't do it alone is because they do not have the money to afford bringing the drug to market. Clinical trials cost too much money!
Where did you get that idea? Those costs are passed directly to the consumer, which is why too many people have to ration their medications or go without them entirely.The market won't bear anything because the cost isn't passed onto the consumer directly nor are we even looking at the effects since we're effectively printing money to cover this.
All of the costs is getting piled into debt, and a lot of that is the national debt (since it's medicare) that no one in congress cares about since it's just a invisible number to them.
What you seem to be missing is that the cost delta is often still picked up by the insurance company, and then everyone else pays for it with the next round of insurance hikes. You the consumer may not see the full bill, but even after discounts the insurance company negotiates, often with itself these days as insurance groups owning the pharmacy and the pharmacy benefit middleman are all the same company still ends up being far more than the actual cost of the drug. Your cost may be low or free, but it's not free to all those insured or the businesses that self insure. You also are missing the bit where the formulary for Medicare Advantage plans can change after you've signed up and a drug that was covered is suddenly not covered and then costs you considerably out of pocket. Medicare Advantage plans have much higher rates of denying coverage, drastically limiting doctors networks but hey, they might throw in a free gym membership...Before people get excited about Massive Price Gouging! and Eeeee-vil Capitalism! might I offer a comment, from the perspective of someone who has filled hundreds of Medicare prescriptions?
I am skeptical of the AARP "study". The prices they are tossing around are "retail" prices, not the actual price the consumer will pay. As the caregiver for my mother, in her final years, I enrolled her in a Medicare Advantage plan that (for $80/month) provided all of her medications at no extra charge. (Medicare Advantage is a [clutch your pearls, kiddees] privatizing of Medicare, where the federal government pays a per-capita fee to a private insurance company to provide better coverage for less money.)
How substantial is the delta between retail pricing and what the doctor, hospital, or pharmacy actually gets paid (and happily accepts)? In my mother's last five weeks of her life, the hospital billed the Medicare Advantage plan $453,000. The plan paid $33,000--and the hospital was perfectly happy.
There's a similar delta between what the retail price of a drug might be, and the actual price paid by the consumer. Month after month after month, I picked up "meds for Mom" and never paid a penny.
The timing of a gang of politicians beating up on pharmaceutical companies in an election year seems...ever so convenient.
One simple solution. Pass a law that mandates that while companies are free to set a price for a drug or product, that price has to apply to ALL customers. No more special rates for other countries, Insurance companies, Medicare or paying cash.
Until drugmakers are forced to negotiate prices, isn't the list price used to determine what the government pays them under Part D to make up for what the consumer pays? At the very least I imagine it forms the starting point. Isn't it similar with private insurance?I am skeptical of the AARP "study". The prices they are tossing around are "retail" prices, not the actual price the consumer will pay.
If you cut out advertising (I know, crazy talk) then there would be plenty left for research including clinical trials. Trails are always going to be expensive. Suck it up, buttercup.The only way to solve this is with competition.
The government needs to examine and eliminate the unofficial and official "non-compete" agreements where large generic companies get paid to delay the release of an off-patent drug.
The government also needs to massively reduce the costs related to FDA approval and trials. The majority of the cost in developing drugs is in the clinical development stage, not discovery.